FDH: an Aldehyde Dehydrogenase Fusion Enzyme in Folate Metabolism
Overview
Molecular Biology
Pharmacology
Authors
Affiliations
FDH (10-formyltetrahydrofolate dehydrogenase, Aldh1L1, EC 1.5.1.6) converts 10-formyltetrahydrofolate (10-formyl-THF) to tetrahydrofolate and CO(2) in a NADP(+)-dependent reaction. It is a tetramer of four identical 902 amino acid residue subunits. The protein subunit is a product of a natural fusion of three unrelated genes and consists of three distinct domains. The N-terminal domain of FDH (residues 1-310) carries the folate binding site and shares sequence homology and structural topology with other enzymes utilizing 10-formyl-THF as a substrate. In vitro it functions as 10-formyl-THF hydrolase, and evidence indicate that this activity is a part of the overall FDH mechanism. The C-terminal domain of FDH (residues 400-902) originated from an aldehyde dehydrogenase-related gene and is capable of oxidation of short-chain aldehydes to corresponding acids. Similar to classes 1 and 2 aldehyde dehydrogenases, this domain exists as a tetramer and defines the oligomeric structure of the full-length enzyme. The two catalytic domains are connected by an intermediate linker (residues 311-399), which is a structural and functional homolog of carrier proteins possessing a 4'-phosphopantetheine prosthetic group. In the FDH mechanism, the intermediate linker domain transfers a formyl, covalently attached to the sulfhydryl group of the phosphopantetheine arm, from the N-terminal domain to the C-terminal domain. The overall FDH mechanism is a coupling of two sequential reactions, a hydrolase and a formyl dehydrogenase, bridged by a substrate transfer step. In this mechanism, one domain provides the folate binding site and a hydrolase catalytic center to remove the formyl group from the folate substrate, another provides a transfer vehicle between catalytic centers and the third one contributes the dehydrogenase machinery further oxidizing formyl to CO(2).
You M, Shamseldin H, Fogle H, Rushing B, AlMalki R, Jaafar A Clin Genet. 2024; 105(5):488-498.
PMID: 38193334 PMC: 10990829. DOI: 10.1111/cge.14479.
The astrocytic Na -HCO cotransporter, NBCe1, is dispensable for respiratory chemosensitivity.
Li K, Gonye E, Stornetta R, Bayliss C, Yi G, Stornetta D J Physiol. 2023; 601(16):3667-3686.
PMID: 37384821 PMC: 10528273. DOI: 10.1113/JP284960.
Xia J, Li S, Liu S, Zhang L MedComm (2020). 2023; 4(1):e195.
PMID: 36694633 PMC: 9842923. DOI: 10.1002/mco2.195.
Rushing B, Fogle H, Sharma J, You M, McCormac J, Molina S Molecules. 2022; 27(23).
PMID: 36500483 PMC: 9740053. DOI: 10.3390/molecules27238394.
Qu Y, He Y, Ruan H, Qin L, Han Z Cancer Med. 2022; 12(5):5781-5797.
PMID: 36336972 PMC: 10028165. DOI: 10.1002/cam4.5327.